Technical Ventures RX Corp. — Investor Relations & Filings
About Technical Ventures RX Corp.
Technical Ventures RX Corp. was the corporate vehicle for a Qualifying Transaction completed in 2014, resulting in the acquisition of TheraVitae Inc. (TVI). The resulting clinical-stage biotechnology operation focuses on the development and commercialization of innovative, autologous (patient's own), blood-derived cell therapies. The company utilizes a proprietary technology platform engineered for the treatment of vascular diseases. Its lead clinical-stage candidate is ACP-01, an autologous cell therapy currently being advanced through clinical trials for vascular applications. This specialization in regenerative medicine leverages the patient's own biological material for personalized therapeutic interventions.
Recent filings
No filings indexed yet
We are still gathering filings for Technical Ventures RX Corp.. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NovoCure Ltd
Develops a non-invasive cancer therapy using electric field…
|
NVCR | JE | Professional, scientific and te… |
|
NOVOGENE CO., LTD.
Global provider of genomic services, NGS solutions, and bio…
|
688315 | CN | Professional, scientific and te… |
|
Novoheart Holdings Inc.
Engineering bioartificial human heart surrogates for drug d…
|
NVH | CA | Professional, scientific and te… |
|
NOVOPROTEIN SCIENTIFIC INC.
Develops recombinant proteins and enzymes for life sciences…
|
688137 | CN | Professional, scientific and te… |
|
NOXOPHARM LIMITED
Clinical-stage developer of novel treatments for cancer and…
|
NOX | AU | Professional, scientific and te… |
|
NUFORMIX PLC
Pharmaceutical developer using cocrystal technology to repu…
|
NFX | GB | Professional, scientific and te… |
|
Nurix Therapeutics, Inc.
Clinical-stage biopharma developing protein degradation the…
|
NRIX | US | Professional, scientific and te… |
|
NYRADA INC.
Develops small molecule therapeutics for cardiovascular hea…
|
NYR | AU | Professional, scientific and te… |
|
OLIPASS CORPORATION
An R&D company developing RNA therapeutics using its propri…
|
244460 | KR | Professional, scientific and te… |
|
OmniAb, Inc.
A technology platform for therapeutic antibody discovery us…
|
OABIW | US | Professional, scientific and te… |
Technical Ventures RX Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47051/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47051 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47051 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47051 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47051}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Technical Ventures RX Corp. (id: 47051)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.